# Sucralfate

NDC: 0904-7470
Generic name: SUCRALFATE Oral Suspension
Labeler / Manufacturer: Major Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20240626

FDA application: ANDA211884

## Active ingredients

- SUCRALFATE: 1 g/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0904-7470"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0904-7470
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=98a8fedd-fa06-416a-8a85-b899631978f9